Low-Level Laser Therapy for Prevention of Oral Mucositis

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

August 2, 2017

Study Completion Date

September 13, 2021

Conditions
Mucositis
Interventions
DEVICE

Low Level Laser Therapy

Patients will receive LLLT three times per week concurrently with chemoradiotherapy. LLLT may be delivered either immediately prior to or after the patient's daily fraction of radiotherapy. Patients will be treated extra-orally with a THOR® LED cluster for one minute along the buccal mucosa on each side and intraorally for one minute to the tongue and soft palate. During each LLLT treatment session a thorough oral exam will be performed to identify any areas of mucositis. If the patient should develop intraoral lesions they will be targeted directly with the intraoral probe for one minute to each site of mucositis. The laser settings to be used are as follows: frequency 2.5 Hz; wavelength 660 nm; and power 75 mW, for an energy of 4.5 J.

Trial Locations (1)

48201

Wayne State University/Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT02723604 - Low-Level Laser Therapy for Prevention of Oral Mucositis | Biotech Hunter | Biotech Hunter